Latest Breaking News On - Research institute translational health science technology - Page 2 : comparemela.com
DGCI nod to Biological E to conduct phase 2/3 clinical trials of its COVID-19 vaccine on children between 5 and 18 years
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
DCGI approves phase 2, 3 trials of Biological E s COVID-19 vaccine for 5-18 years
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Health Minister Mansukh Mandaviya Meets Top Vaccine Bosses From SII, Biological-E, Dr Reddy s
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
URL copied
Centre finalises advance deal with Hyderabad-based firm for 30 crore Covid vaccine doses
The Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-EÂ from August-December 2021.Â
For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E.Â
The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.Â